The dashboard said the brand was profitable. Gross margin across the catalog: 42%. Healthy by any CPG benchmark. The founder was planning a new product launch.

We asked one question: "What is the margin on your best-selling SKU?"

Silence. Then: "It has to be good. It is our best seller."

It was not good. It was 11%. The best-selling product, the one driving 35% of total revenue, was barely breaking even after freight and co-packing. The dashboard was telling the truth in aggregate and lying by omission at the SKU level.

This is how most product businesses die. Not from a catastrophic failure. From a profitable-looking catalog that hides a bleeding bestseller.

The First Instinct (And Why We Did Not Run With It)

The obvious move was to raise the price on the bestseller. Margin is too low, price goes up. Simple.

We did not do it. Here is why.

The bestseller was the entry point. It was the product that got new customers into the brand. Forty percent of first-time orders included it. Raising its price would increase margin per unit and decrease the number of new customers who tried the brand at all.

We ran the math both ways. A 15% price increase on the bestseller would recover roughly 8,000 per quarter in margin. But the modeled drop in new customer acquisition would cost 12,000 to 15,000 in downstream revenue from repeat purchases over the following twelve months.

The product was not underpriced. It was miscast. It was doing the job of a customer acquisition tool, but the cost sheet was built as if it were a margin driver.

We needed a different frame.

The Catalog Is a Portfolio, Not a List

Most founders think about their products the way a restaurant owner thinks about a menu: a list of things for sale. Each item needs to earn its place. If a product does not make money, cut it or raise the price.

That works when every product is independent. In CPG, products are not independent. They interact. The bestseller brings in customers. The mid-tier products sustain the relationship. The premium SKU drives margin.

The right frame is not "does this product make money." The right frame is "what role does this product play in the portfolio, and is the portfolio making money."

This is Portfolio Margin, Not Product Margin.

The Framework: Three Rules

Rule 1. Every SKU gets a role. There are three: Acquisition (gets customers in the door), Retention (keeps them buying), and Margin (generates profit). A product can play one role. Not two. Not "a little of both." One.

Rule 2. Acquisition SKUs are allowed to run thin. Their job is not to generate profit. Their job is to generate customers. You measure them on conversion rate and repeat purchase rate, not margin. If the bestseller converts 40% of first-time buyers and 30% of them come back within 90 days, it is doing its job at 11% margin.

Rule 3. Margin SKUs must subsidize the portfolio. For every dollar the acquisition SKU leaves on the table, the margin SKU picks it up. The portfolio target is what matters: 40%+ blended gross margin. Not 40% on every line.

When we applied this frame to the catalog, the problem shifted. The bestseller was not broken. The margin SKUs were underperforming. Two premium products that should have been running at 55-60% gross margin were actually at 38% and 41%. The portfolio was thin because the products designed to carry it were not pulling their weight.

The Cost Sheet Autopsy

We pulled the cost sheet on the two underperforming margin SKUs and went line by line.

Ingredients. One product used high-cost high-runner ingredients that had been locked in at a contract price eighteen months ago. The contract had expired. The brand was now buying spot, and the ingredient cost had increased 22% without anyone updating the cost sheet.

Co-packing. The co-packer's rate had a volume tier. Both products were being produced at a quantity just below the tier break. Increasing the run size by 12% would drop the per-unit co-packing cost by 9%.

Packaging. The premium label was a custom die-cut. The die-cut cost 0.14 per unit more than a standard rectangle label. On 10,000 units, that is 1,400 in margin the label was eating.

Freight. The products shipped in a box designed for the bestseller. They were slightly larger, which meant more void fill and a higher dimensional weight. The freight cost per unit was 18% higher than it needed to be.

Total margin leak across the two SKUs: roughly 14 points. Not from one catastrophic error. From four small ones that nobody had looked at in over a year.

The Ingredient Swap Protocol

The biggest single lever was the ingredient cost on the first margin SKU. Here is the protocol we ran:

Step 1. List every ingredient by cost-per-unit contribution. Sort descending. The top three ingredients by cost are the only ones worth optimizing. Everything else is noise.

Step 2. For each of the top three, identify one functionally equivalent alternative at a lower price point. "Functionally equivalent" means the product performs the same way. Not "similar." The same. The customer cannot tell the difference.

Step 3. Run a small batch with the alternative ingredient. Test internally. If it passes, test with five loyal customers. Do not tell them what changed. Ask: "Does this taste/feel/perform the way you expect?" If four out of five say yes, the swap is validated.

Step 4. Negotiate the new ingredient on contract, not spot. Lock in six months minimum. Spot pricing is how the margin leaked in the first place.

The ingredient swap on one SKU recovered 7 points of gross margin. Combined with the co-packing volume adjustment and the packaging simplification, the two margin SKUs moved from 38% and 41% to 56% and 53%.

The Portfolio Rebalance

With the margin SKUs performing, we rebuilt the portfolio math:

Before:

After:

We did not touch the bestseller. We did not raise a single retail price. We fixed the cost structure on the products whose job was to generate margin, and the portfolio moved from 33% to 37%. Over the next quarter, as the co-packing volume tier kicked in and the ingredient contract landed, the blended margin settled at 39%.

The founder's reaction: "We were about to raise the price on the product that brings in all our customers."

That price increase would have recovered 8,000 per quarter. The portfolio rebalance recovered 18% in blended margin. On an annualized basis, the difference was roughly 40,000.

What We Would Do Differently

Two things.

First, we should have run the cost sheet autopsy on every SKU at the start, not just the margin SKUs. We focused on the underperformers because they were the obvious problem. But we later found a mid-tier product with a freight cost that was 25% too high because it was shipping in the wrong box. That took another six weeks to catch.

Second, we should have built a quarterly cost review into the operating rhythm from day one. Ingredient prices change. Co-packer rates change. Packaging costs change. A cost sheet is not a document. It is a living instrument. If nobody reviews it quarterly, it drifts. And drift is how 14 points of margin disappear without anyone noticing.

The Template for Builders

If you run a product business with more than five SKUs, here is the exercise:

  1. Assign every SKU a role. Acquisition, Retention, or Margin. One role each. No exceptions.

  2. Pull the cost sheet on every Margin SKU. Go line by line: ingredients, co-packing, packaging, freight. Flag anything that has not been reviewed in six months.

  3. Calculate your blended portfolio margin. Weight each SKU's margin by its revenue share. If the blended number is below 40%, your margin SKUs are not doing their job.

  4. Run the Ingredient Swap Protocol on the top cost driver. One ingredient. One swap. One small batch. Validate before you scale.

  5. Set a quarterly cost review. Put it on the calendar. Thirty minutes. Pull the cost sheet, compare to actuals, flag drift. This one habit would have prevented the entire problem we just described.

The product that sells the most is not always the product that matters most. The portfolio is the unit of analysis. Manage accordingly.

Ops Intel

A few things we are watching this week:

Coca-Cola reported Q1 volume growth of 2% globally but noted that price/mix contributed more to revenue than unit volume. Translation: they are managing a portfolio, not a price list. Even the largest CPG company on earth thinks in portfolio margin, not product margin.

P&G raised prices on 8 of its 10 product categories in the last 12 months. But their fastest-growing segment, health and wellness, actually saw price decreases. The acquisition SKUs are running thin on purpose. The rest of the portfolio subsidizes them.

Section 232 tariffs on aluminum and steel are now fully in effect. If your packaging uses aluminum (cans, pouches with foil layers, some closures), your packaging cost line is about to move. Check your cost sheet before your co-packer checks it for you.

SMBs are feeling input cost pressure. The NFIB Small Business Optimism Index showed that 24% of small business owners cited cost of materials as their single most important problem. That is the highest reading since 2022. If you have not reviewed your cost sheet in six months, you are already behind.

The Conference Board revised its 2026 GDP forecast down to 1.6% from 2.0%. Consumer spending is expected to slow. In a tightening market, the brands that survive are the ones with margin discipline. Portfolio margin is not a luxury when growth slows. It is how you stay alive.